fiercepharma.com
Link authority for fiercepharma.com (registrable domain: fiercepharma.com) from the Common Crawl web graph: PageRank and harmonic centrality history since 2017, current scores, and the site's top backlink sources.
Web-graph authority (0-100)
Domain scores measure fiercepharma.com as a whole: every subdomain's links rolled up into one node of Common Crawl's domain-level web graph. Host scores measure the exact hostname fiercepharma.com. WWW scores cover the www variant of that hostname, which the graph tracks as its own entry since January 2026 (before that, www and bare host were merged). A big gap between domain and host usually means the domain's authority lives on other subdomains. PageRank is link-endorsement authority: how much weight the sites linking here carry themselves. Harmonic centrality measures reach: how close this site sits to the rest of the web when following links, which favors broadly connected sites over ones boosted by a few heavy linkers. All are normalized 0 to 100 within each crawl snapshot; a dash means that series does not exist for this site.
Homepage
What fiercepharma.com presents on its own homepage: the page title, description, and the social share markup it publishes. Pulled from https://www.fiercepharma.com.
| Title | Fierce Pharma Biopharma News & Insights |
|---|---|
| Description | Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance. |
| OG Title | Fierce Pharma |
Social accounts and contact points
Where this site maintains a presence and every reachable route its homepage exposes: social accounts, contact pages, addresses, and content feeds.
| fierce-pharma (business) | |
| X | fiercepharma |
| Feeds | https://www.fiercepharma.com/rss/Fierce%20Pharma%20Homepage/xml |
|---|
Structured data (JSON-LD)
The schema.org markup this homepage publishes: the machine-readable identity search engines and AI systems read. Types found: ItemList, WebSite, Organization.
JSON-LD block (5,698 bytes)
{"@context":"https://schema.org/","@type":"ItemList","url":"https://www.fiercepharma.com/fierce-pharma-homepage","numberOfItems":10,"itemListElement":[{"@type":"ListItem","position":1,"item":{"@type":"Article","url":"https://www.fiercepharma.com/marketing/foundation-medicine-launches-quality-first-initiative-stand-out-cancer-testing-market","name":"Foundation Medicine launches 'Quality First' initiative to stand out in cancer testing market","description":"Foundation Medicine has started the \u201cQuality First\u201d initiative to create awareness of how \u201cnot all cancer biomarker tests are created equal.\u201d","image":"https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1477214805.jpg?VersionId=8g3KMat7I5Nvm.y9uzFuisGcAP1j9bkQ"}},{"@type":"ListItem","position":2,"item":{"@type":"Article","url":"https://www.fiercepharma.com/marketing/lights-camera-action-cg-life-spotlight-rare-disease-dedicated-film-festival","name":"Lights, camera, action: CG Life to spotlight rare disease in dedicated film festival","description":"CG Life and its rare disease awareness platform 24/364 will host a first-of-its-kind rare disease film festival in San Diego next March. ","image":"https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1855196702.jpg?VersionId=lyQMOH85aELsmlKyLi1BEpxNqTE.cQpq"}},{"@type":"ListItem","position":3,"item":{"@type":"Article","url":"https://www.fiercepharma.com/manufacturing/huahai-poaches-quality-chief-hengrui-amid-fda-manufacturing-citations","name":"Huahai poaches quality chief from Hengrui amid FDA manufacturing citations","description":"The appointment comes as Huahai is working through a 24-page, 13-observation Form 483 that the FDA slapped on one of its manufacturing facilities.","image":"https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1324419719_0.jpg?VersionId=SEUpdkAs.9FByz6VaErjb.YpkdWYHWMB"}},{"@type":"ListItem","position":4,"item":{"@type":"Article","url":"https://www.fiercepharma.com/marketing/vanda-shifts-nereus-marketing-high-gear-schumacher-indycar-sponsorship","name":"Vanda shifts Nereus marketing into high gear with Schumacher IndyCar sponsorship","description":"The biotech backed the No. 47 car to represent its ending of the multi-decade wait for a prescription therapy.","image":"https://qtxasset.com/quartz/qcloud5/media/image/vanda-pharmaceuticals-inc-nereus.jpg?VersionId=PovjLikGPToTp3hsWozIQneLUK__CYnM"}},{"@type":"ListItem","position":5,"item":{"@type":"Article","url":"https://www.fiercepharma.com/manufacturing/bipartisan-senate-bill-seeks-build-vigilance-around-foreign-companies-making-drugs-us","name":"Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US","description":"Although the bill does not single out any specific country, at least one of its three co-sponsors has one name in mind: China.","image":"https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-637189564%20%282%29.jpg?VersionId=HcEbagt.YOtkQVRw3roQO3uc2EWN6NJf"}},{"@type":"ListItem","position":6,"item":{"@type":"Article","url":"https://www.fiercepharma.com/pharma/merck-scores-fda-nod-lipfendra-becomes-first-oral-pcsk9-treatment","name":"Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment","description":"The FDA has approved Merck's cholesterol-lowering daily pill Lipfendra. The PCSK9 inhibitor has been cleared for adults with hypercholesterolemia.","image":"https://qtxasset.com/quartz/qcloud5/media/image/MERCKWALK.jpg?VersionId=UxVEhgM4AMUzScNDxFn16wbrVE8CPT_Q"}},{"@type":"ListItem","position":7,"item":{"@type":"Article","url":"https://www.fiercepharma.com/marketing/otters-bears-and-pharma-lions-inside-gileads-bronze-winning-cannes-spot","name":"Otters, bears and Pharma Lions: inside Gilead\u2019s bronze-winning Cannes spot","description":"Gilead Sciences Canada and The Local Collective worked up a bronze-winning campaign for HIV med Descovy featuring AI-generated animals. ","image":"https://qtxasset.com/quartz/qcloud5/media/image/descovy_dooh_v2_1920x1080.jpg?VersionId=jX2q2arinTCvPO_3IEa2y5Uu0dwZ8B81"}},{"@type":"ListItem","position":8,"item":{"@type":"Article","url":"https://www.fiercepharma.com/pharma/merck-touts-keytruda-front-line-win-endometrial-cancer-subtype-pd-1-first","name":"Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first","description":"The news follows Merck's recent positive endometrial cancer readout from the first global phase 3 trial of its Kelun-Biotech-partnered sac-TMT.","image":"https://qtxasset.com/quartz/qcloud5/media/image/Merck_2.jpg?VersionId=6Jhc.dNmOgx466ImJKUce2gG5qfVm9fH"}},{"@type":"ListItem","position":9,"item":{"@type":"Article","url":"https://www.fiercepharma.com/pharma/sanofi-opens-new-chapters-pfizers-modernas-mrna-patent-litigation-sagas","name":"Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas","description":"As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new front.","image":"https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2165663502.jpg?VersionId=bRHkAfJ2udDglZzvCMsyawk_HBwEbJyM"}},{"@type":"ListItem","position":10,"item":{"@type":"Article","url":"https://www.fiercepharma.com/pharma/novo-gets-head-start-lilly-europe-ec-approval-wegovy-pill-0","name":"Novo gains head start on Lilly with European Commission approval of Wegovy pill","description":"Europe has approved Novo Nordisk\u2019s Wegovy pill, with the decision coming as Eli Lilly awaits European approval of its oral GLP-1 drug, Foundayo.","image":"https://qtxasset.com/quartz/qcloud5/media/image/WEGOVYPILL.jpg?VersionId=1kIxgP5EyCmNyYl3qBCWLR7JHArXf8K_"}}]}JSON-LD block (295 bytes)
{"@context":"http://schema.org","@type":"WebSite","name":"Fierce Pharma","url":"https://www.fiercepharma.com/","potentialAction":{"@type":"SearchAction","target":"https://www.fiercepharma.com/search-results?fulltext_search={search_term_string}","query-input":"required name=search_term_string"}}JSON-LD block (1,362 bytes)
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"sameAs": [
"https://twitter.com/fiercepharma",
"https://www.linkedin.com/showcase/fierce-pharma/"
],
"name": "Fierce Pharma",
"url": "https://www.fiercepharma.com/",
"logo": {
"@type": "ImageObject",
"url": "https://qtxasset.com/quartz/qcloud5/logos/Fierce%20Pharma%20Mix%20Logo.svg"
},
"image": {
"@type": "ImageObject",
"url": "https://qtxasset.com/quartz/qcloud5/logos/Fierce%20Pharma%20Mix%20Logo.svg"
},
"memberOf": {
"@type": "Organization",
"name": "Questex",
"url": "https://questex.com",
"telephone": "888.552.4346 +1.212.895.8200",
"address": {
"@type": "PostalAddress",
"streetAddress": [
"1111B S Governors Ave",
"STE 25792"
],
"addressLocality": "Dover",
"addressRegion": "DE",
"postalCode": "19904",
"addressCountry": "US"
}
}
}
]
}Authority over time
Every Common Crawl web-graph release since 2017, roughly quarterly. The domain series goes back to 2017; Common Crawl only began publishing the host-level graph in 2020, so host lines start there. Click a legend entry to show or hide that line. Flat lines are normal for established sites; watch for sustained rises or drops, which track real gains or losses in who links here.
A note on www: through the end of 2025 the source web graph merged www and non-www hostnames into the bare name, so one host line covers both. Starting in January 2026 the graph splits them into separate entries, which is why www can carry its own scores going forward.
Backlink counts
Unique linking domains seen in Common Crawl's link graphs. This is a different dataset than the 0-100 authority scores above: these are raw counts, host-level for fiercepharma.com and domain-level for fiercepharma.com with all its subdomains combined. Common Crawl covers a large sample of the web, not all of it, so treat counts as comparable between sites rather than absolute totals.
Top backlinks in the domain graph
Common Crawl publishes two link graphs. The DOMAIN graph connects whole domains: every link from any page of one domain to any page of another. This table shows the highest-authority domains linking to fiercepharma.com (including its subdomains), ranked by the linker's PageRank. The table shows the top 1,000; the download carries the full stored list (up to 10,000 linkers) as JSON. Click a linker for its own site profile.
Top backlinks in the host graph
The HOST graph connects exact hostnames, so subdomains count separately. This table shows the highest-authority hosts linking to fiercepharma.com specifically, ranked by the linker's PageRank. The table shows the top 61; the download carries the full stored list (up to 10,000 linkers) as JSON. Click a linker for its own site profile.